期刊文献+

Ber对肝HepG2细胞Insig-2和VDR基因表达的影响 被引量:4

Effects of berberine on Insig-2 and VDR gene expression of HepG2 cell line
下载PDF
导出
摘要 目的:研究小檗碱(berberine,Ber)对人肝癌细胞株HepG2细胞中胰岛素诱导基因2(Insulin-induced gene 2,Insig-2)和维生素D受体(Vitamin D receptor,VDR)基因表达的影响,探讨其调血脂的作用机制。方法:采用RT-PCR技术检测不同浓度(1、3、10、30、100μmol/L)Ber处理24 h后及3μmol/L Ber处理不同时间(0、12、24、48、72 h)后HepG2细胞中In-sig-2和VDR mRNA的表达,并进行相关性分析。结果:不同浓度Ber处理HepG2细胞后,Insig-2及VDR基因的表达均明显上调,其上调效应随药物浓度的升高而逐渐增强,至3μmol/L浓度时达高峰,随后则逐渐减弱,两者的变化具有相关性,r=0.753(P<0.01);用3μmol/L浓度Ber处理HepG2细胞不同时间后,Insig-2及VDR基因的表达均明显上调,其效应随着时间的延长而不断增强,于48 h达峰值,随后减弱,两者的变化具有相关性,r=0.922(P<0.01)。结论:Ber调血脂的作用机制可能是通过上调VDR的表达,进而上调Insig-2基因表达,从而抑制肝脏中胆固醇的合成代谢。 AIM : To observe the mRNA expressions of Insulin-induced gene 2 (Insig-2) and Vitamin D receptor (VDR) in HepG2 cell line and investigate the possible mechanism of berberine on regulating blood lipid. METHODS: HepG2 ceils were incubated with Bet at different concentrations (1, 3, 10, 30, 100 p, mol/L), and incubated with 3 p, mol/L berberine for various times (0, 12, 24, 48, 72 h). Total RNA was extracted and the mRNA expressions of Insig-2 and VDR from HepG2 ceils treated by berberine were quantified by RT-PCR. RESULTS: After exposure to gradient concentrations of berberine for 24 h, the mRNA expressions of Insig-2 and VDR in HepG2 ceils increased obviously peaked at 3 p, mol/L concentration, then the up-regulating effect declined gradually. The relative coefficient between them was 0.753 (P 〈 0.01 ). After being treated with 3 p, mol/L berberine for different time, the mRNA expression of Insig-2 and VDR in HepG2 ceils significantly increased with the prolongation of the exposure time, peaked at 48 h, then declined at 72 h. The relative coefficient between them was 0.922 (p 〈 0.01 ). CONCLUSION: Berberine can increase the mRNA expression of Insig-2 and VDR in HepG2 cell. The possible mechanisms of its effects for lowering blood lipid may be relevant to up-regulating VDR and Insig-2 gene expression and inhibiting cholesterol synthesis.
出处 《中成药》 CAS CSCD 北大核心 2008年第7期965-968,共4页 Chinese Traditional Patent Medicine
基金 国家自然科学基金资助项目(30600812)
关键词 小檗碱 Insig-2 VDR 基因表达 降血脂 berberine Insig-2 VDR gene expression hypolipidemic
  • 相关文献

参考文献6

  • 1周丽斌,陈名道,王晓,宋怀东,杨颖,唐金凤,李凤英,许曼音,陈家伦.小檗碱对脂肪细胞分化的影响[J].中华医学杂志,2003,83(4):338-340. 被引量:48
  • 2Iizuka N, Hazama S, Yoshimura K, et al. Anticachectic effects of the natural herb Coptidis rhizoma and berberine on mice bearing colon 26/clone 20 adenocarcinoma [ J]. lnt J Cancer, 2002, 99 (2) :286-291.
  • 3Kuo CL, Chi CW, Liu TY. The anti-inflammatory potential of berberine in vitro and in vivo[ J]. CancerLett, 2004, 203(2) : 127- 137.
  • 4Yabe D, Brown M S, Goldstein J L. Insig-2, a second endoplasmic reticuium protein that binds SCAP and blocks export of sterol regulatory element-binding proteins[J]. Proc Natl Acad Sci USA, 2002, 99(20) : 12753-12758.
  • 5Lee S, Lee D K, ChoI E, et al. Identification of a functional vitamin D response element in the murine Insig-2 promoter and Its potential role in the differentiation of 3T3-L1 Preadipocytes[ J]. Mol Endocrinol,2005, 19(2) :399-408.
  • 6Kong W, Wei J, Abidi P, et al. Berberine is a novel cholesterollowering drug working through a unique mechanism distinct from statins[J]. Nat Med, 2004, 10(12) :1344-1351.

二级参考文献9

  • 1Spiegelman BM, Flier JS. Obesity and the regulation of energy balance. Cell, 2001,104:531-543.
  • 2Prins JB, O′Rahilly S. Regulation of adipose cell number in man. Clin Sci, 1997,92:3-11.
  • 3Yin J, Hu RM, Chen MD, et al. Effect of berberine on glucose metabolism in vitro. Metabolism,2002, 51:1439-1443.
  • 4Hansen MB, Nielsen SE, Berg K. Re-examination and further development of a precise and rapid dye method for measuring cell growth/cell kill. J Immunol Method, 1989,119:203-210.
  • 5Ross SA, Chen XL, Hope H, et al. Development and comparison of two 3T3-L1 adipocyte models of insulin resistance: increased glucose flux vs glucosamine treatment. Biochem Biophys Res Commun, 2000, 273: 1033-1041.
  • 6Kahrr BB, Flier JS. Obesity and insulin resistance. J Clin Invest, 2000, 106:473-480.
  • 7Matthaei S, Stumvoll M, Kellerer M, et al. Pathophysiology and pharmacological treatment of insulin resistance. Endo Rev, 2000, 21: 585-618.
  • 8Fajas L, Fruchart JC, Auwerx J. Transcriptional control of adipogenesis. Current Opinion in Cell Biology, 1998,10:165-173.
  • 9谢明智.中药抗糖尿病的药理作用[J].中国中西医结合杂志,2001,21(4):318-320. 被引量:46

共引文献47

同被引文献35

引证文献4

二级引证文献17

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部